Document Detail


Angiotensin converting enzyme inhibition and vascular hypertrophy in hypertension.
MedLine Citation:
PMID:  2285616     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The pathogenesis of hypertension is associated with a remodeling of vascular structure. Follow has postulated that the decreased luminal area and thickened medial layer in hypertensive vessels enhances the vasoconstrictive response to vasoactive agents. It is hypothesized that this increase in vascular reactivity may serve to perpetuate hypertension. A growing body of evidence suggests that autocrine-paracrine vasoactive substances and growth factors modulate vascular structure in hypertension. We speculate that therapeutic interventions that normalize blood pressure as well as reverse the vascular remodeling process may have special clinical value. The role of the paracrine renin-angiotensin system and angiotensin converting enzyme inhibitors in hypertension is discussed in this context.
Authors:
G H Gibbons; V J Dzau
Related Documents :
6989756 - Mechanism of enhanced blood pressure rise after reclipping following removal of a renal...
2932646 - Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte ...
25373466 - Identifying predictors of blood pressure control in the lebanese population - a nationa...
25340166 - Association of serum lipids with level of blood pressure in type 2 diabetic patients.
1756996 - Antithromboxane drug in the treatment of preeclampsia.
2330906 - Effects of indapamide on the mechanical properties of the arterial wall in deoxycortico...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review    
Journal Detail:
Title:  Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy     Volume:  4     ISSN:  0920-3206     ISO Abbreviation:  Cardiovasc Drugs Ther     Publication Date:  1990 Feb 
Date Detail:
Created Date:  1991-03-22     Completed Date:  1991-03-22     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  8712220     Medline TA:  Cardiovasc Drugs Ther     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  237-42     Citation Subset:  IM    
Affiliation:
Molecular and Cellular Vascular Research Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Animals
Arteries / pathology
Biomechanics
Blood Vessels / drug effects,  pathology*
Hormones / physiology
Humans
Hypertension / drug therapy*
Hypertrophy / drug therapy
Muscle, Smooth, Vascular / pathology
Grant Support
ID/Acronym/Agency:
HL19259/HL/NHLBI NIH HHS; HL35252/HL/NHLBI NIH HHS; HL35610/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Angiotensin-Converting Enzyme Inhibitors; 0/Hormones

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  ACE inhibitors in renovascular hypertension.
Next Document:  Cardiac effects of angiotensin converting enzyme inhibitors.